Loading...
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| BUD | Anheuser-Busch InBev SA/NV | A+ | $151.1B | $84.06 | 24.80 | $64B | 15.4% |
| ABEV | AMBEV S.A. | C+ | $44.2B | $2.81 | 15.42 | $16.2B | 17.6% |
| TAP | Molson Coors Beverage Company | D | $7B | $39.68 | — | $13B | -16.4% |
| SAM | THE BOSTON BEER COMPANY, INC. | F | $2.2B | $219.41 | — | $1.9B | -3.8% |
| CCU | UNITED BREWERIES CO INC | B | $2B | $10.67 | — | $3B | 4.7% |
| FMX | Mexican Economic Development, Inc. | B | — | $132.54 | — | $41.3B | 5.1% |
| STZ | CONSTELLATION BRANDS, INC. | B+ | — | $144.16 | — | $9.2B | 20.9% |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.